Matches in Wikidata for { <http://www.wikidata.org/entity/Q64140202> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q64140202 description "clinical trial" @default.
- Q64140202 description "ensayu clínicu" @default.
- Q64140202 description "klinisch onderzoek" @default.
- Q64140202 description "клінічне випробування" @default.
- Q64140202 name "A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve CLL or SLL" @default.
- Q64140202 type Item @default.
- Q64140202 label "A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve CLL or SLL" @default.
- Q64140202 prefLabel "A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve CLL or SLL" @default.
- Q64140202 P1050 Q64140202-526CA2E4-0688-4B29-8774-3ED095B0B64A @default.
- Q64140202 P1050 Q64140202-6862EDEB-733C-49C6-934C-3C263CAFA63A @default.
- Q64140202 P1132 Q64140202-1CC20DD0-AFAB-4B3C-8BC6-265F51E22026 @default.
- Q64140202 P1476 Q64140202-C2FC2C50-A7C2-4BCC-8F94-EC8C671C612E @default.
- Q64140202 P17 Q64140202-10FB2CAB-A89F-4E93-97F6-71CF87A6F7A3 @default.
- Q64140202 P17 Q64140202-2233A89D-BC05-4BD0-A215-5041EA244E56 @default.
- Q64140202 P17 Q64140202-231A0B5E-D0D8-4849-8BDD-9E3BC003215F @default.
- Q64140202 P17 Q64140202-2E538D03-F799-4FA3-811F-5C1D7EDCE512 @default.
- Q64140202 P17 Q64140202-3DF2D23E-621D-4CC9-B109-894C890AE940 @default.
- Q64140202 P17 Q64140202-4855C073-06CA-4C3F-B282-D87942AC747C @default.
- Q64140202 P17 Q64140202-4CD083ED-F1F3-4277-96FA-95C7A1AC0A46 @default.
- Q64140202 P17 Q64140202-59D9ED73-822A-4D37-9EFB-7EB339042E6C @default.
- Q64140202 P17 Q64140202-6EE77D16-8439-4526-950E-2CD6D8D4BBC6 @default.
- Q64140202 P17 Q64140202-7189ADC9-D1A0-490A-BFC6-5289E832511D @default.
- Q64140202 P17 Q64140202-7F9BAD41-D8D6-4105-9ED0-A9F06D88B93C @default.
- Q64140202 P17 Q64140202-828D6DA1-958B-4969-B1A8-8A3AB0370BB8 @default.
- Q64140202 P17 Q64140202-8CFC728B-7929-4B1C-8876-E06930B66FF2 @default.
- Q64140202 P17 Q64140202-9ACEFE5B-B7FE-4B49-9A84-86DE73E6D752 @default.
- Q64140202 P2899 Q64140202-99BE07E0-35D0-4967-856B-5C94175A90AC @default.
- Q64140202 P3098 Q64140202-10F7DE6D-0F2A-47EC-8669-36A6CDAD4E1E @default.
- Q64140202 P31 Q64140202-3EE21282-2ABE-4328-BC2A-40F2F106B989 @default.
- Q64140202 P4844 Q64140202-FFD0EAEB-EA6D-47FB-894F-4E06467BE908 @default.
- Q64140202 P580 Q64140202-78128D7E-A65C-4FF1-A2B3-F261BAA741E4 @default.
- Q64140202 P582 Q64140202-3749DD89-FE8C-49E4-A310-AFFB7E03B062 @default.
- Q64140202 P6099 Q64140202-0EAA7F14-E55E-43BD-A727-2D014C118152 @default.
- Q64140202 P8363 Q64140202-3FF3941A-2821-470F-B097-31735AB5F810 @default.
- Q64140202 P1050 Q208414 @default.
- Q64140202 P1050 Q29496 @default.
- Q64140202 P1132 "+229" @default.
- Q64140202 P1476 "A Randomized, Multi-center, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Subjects With Treatment-naïve Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma" @default.
- Q64140202 P17 Q142 @default.
- Q64140202 P17 Q145 @default.
- Q64140202 P17 Q16 @default.
- Q64140202 P17 Q29 @default.
- Q64140202 P17 Q30 @default.
- Q64140202 P17 Q31 @default.
- Q64140202 P17 Q34 @default.
- Q64140202 P17 Q36 @default.
- Q64140202 P17 Q38 @default.
- Q64140202 P17 Q40 @default.
- Q64140202 P17 Q408 @default.
- Q64140202 P17 Q43 @default.
- Q64140202 P17 Q664 @default.
- Q64140202 P17 Q801 @default.
- Q64140202 P2899 "+18" @default.
- Q64140202 P3098 "NCT02264574" @default.
- Q64140202 P31 Q30612 @default.
- Q64140202 P4844 Q415939 @default.
- Q64140202 P580 "2014-10-01T00:00:00Z" @default.
- Q64140202 P582 "2018-03-26T00:00:00Z" @default.
- Q64140202 P6099 Q42824827 @default.
- Q64140202 P8363 Q78089383 @default.